Gruss Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Gruss Capital Management’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-538,000	Closed	-$775K	–	64
2016 Q1	$775K	Hold	538,000	–	–	0.02%	50
2015 Q4	$958K	Hold	538,000	–	–	0.03%	78
2015 Q3	$457K	Hold	538,000	–	–	0.01%	79
2015 Q2	$422K	Hold	538,000	–	–	0.01%	70
2015 Q1	$311K	Buy	538,000 +49,000	+10%	+$26.2K	0.01%	70
2014 Q4	$264K	Buy	489,000 +124,785	+34%	+$290K	0.01%	86
2014 Q3	$1.07M	Buy	+364,215	New	+$1.03M	0.05%	66

Other funds holding SPHS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Gruss Capital Management's SPHS Position: Q2 2016 in Review

Gruss Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q2 2016, closing a stake of 538,000 shares — an estimated $775K sold.

Gruss Capital Management first reported a position in SPHS in Q3 2014 and held it in 7 quarters. The position peaked at $1.07M in Q3 2014. 19 funds tracked by Wall St. Rank hold SPHS as of Q2 2016.

Gruss Capital Management reported no remaining Sophiris Bio, Inc. position as of Q2 2016 after selling out during the quarter.
Gruss Capital Management sold 538,000 Sophiris Bio, Inc. shares in Q2 2016, an estimated $775K.
Gruss Capital Management first reported a position in Sophiris Bio, Inc. in Q3 2014 and held it in 7 quarters.
Gruss Capital Management's Sophiris Bio, Inc. position peaked at $1.07M in Q3 2014.
19 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2016.

Based on Gruss Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.